United Therapeutics Corporation technical analysis
Technical analysis of United Therapeutics Corporation (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.
What is United Therapeutics Corporation
United Therapeutics Corporation is a pharmaceutical company that develops and commercializes medicines to address chronic and life-threatening diseases, with a focus on pulmonary arterial hypertension, idiopathic pulmonary fibrosis, and high-risk neuroblastoma. Its product portfolio includes inhaled, oral, and injectable formulations, along with development-stage programs in xenotransplantation and regenerative medicine.
Description generated automatically from public sources; it may be inaccurate or out of date.
United Therapeutics Corporation: latest session data
Closing values for October 20, 2026, computed on the last 12 months of prices.
Moving averages
21 sessions
526.76 $
+4.21%
50 sessions
515.14 $
+6.56%
200 sessions
527.53 $
+4.06%
Session levels
s2
520.53
Support
s1
531.84
Support
pivot
545.92
Pivot
r1
557.23
Resistance
r2
571.31
Resistance
How to read it
In the October 20, 2026 session United Therapeutics Corporation closed higher at 548.95 $, +1.07% versus the previous session.
The price sits above every moving average observed: +4.21% against the 21-session average, +6.56% against the 50 and +4.06% against the 200.
The 14-period RSI reads 58.7, in neutral territory.
MACD stands at 9.772 against a signal line at 9.105: the histogram is positive (+0.667).
ADX reads 19.1, indicating weak directionality.
Levels computed on the latest session place supports at 531.84 and 520.53 $ and resistances at 557.23 and 571.31 $, around a pivot of 545.92.
The average daily range (ATR) is 19.671 $, or 3.58% of price.
Turnover was 243.3K shares, 27% of the 20-session average.
Over the last twelve months the price ranged between 468.97 and 609.35 $, and today stands −9.91% from the period high.
Measures computed on closing prices. They describe the past; they are not forecasts.
Score, Elliott Waves, moving averages and technical indicators — free, no card
If you're not registered we'll ask you to sign in (free), then open the UTHR analysis.
How Montbon’s technical analysis works
Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.
Elliott Waves
Wave counting to frame the price structure.
MTF moving averages
Moving averages across timeframes to read the trend.
0–100 score
A technical summary of the setup, updated daily.
FAQ about United Therapeutics Corporation
How is United Therapeutics Corporation analysed technically?
Technical analysis of United Therapeutics Corporation is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.
Which timeframes are used for United Therapeutics Corporation?
The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.
What are Elliott Waves applied to United Therapeutics Corporation?
Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to United Therapeutics Corporation it helps frame the technical structure of the historical chart and is not a forecast.
Other tickers to analyse
Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.
Are you an issuer and want a correction or removal? Write to info@montbon.com.